Unlocking Insights of Ovarian Cancer Maintenance Therapy | ICTC Dr Rohit Pai
Welcome to an insightful panel discussion moderated by Dr. Rohit Pai, an esteemed figure in oncology from ICTC Sion. As we approach Ovarian Cancer Awareness Month, this discussion delves into a critical question: "Do Bevacizumab & Rucaparib have their place in maintenance therapy of Ovarian Cancer - Where & Why?"
Throughout this engaging conversation, Dr. Rohit Pai leads a distinguished panel of experts to explore the nuanced role of Bevacizumab & Rucaparib in the maintenance therapy landscape of ovarian cancer. With his expertise and guidance, the panel scrutinizes the efficacy, indications, and potential advancements of these therapies, offering valuable insights for clinicians, researchers, and patients alike.
Join us as we navigate through the complexities of ovarian cancer treatment strategies, shedding light on the optimal utilization of Bevacizumab & Rucaparib in maintenance therapy. Don't miss this opportunity to gain comprehensive understanding and stay informed during Ovarian Cancer Awareness Month. Subscribe
#ovariancancer #ovarian #ovariancancerawareness #cancerawareness #ictc #drrohitpai #indiancancertreatmentcentre #bevacizumab #rucaparib #maintenancetherapy